Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign

[1]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[2]  C. Sprung,et al.  Steroid therapy of septic shock. , 2011, Critical care nursing clinics of North America.

[3]  C. Sprung,et al.  Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry , 2010, Critical care.

[4]  B. Nathanson,et al.  Activated protein C and hospital mortality in septic shock: A propensity-matched analysis* , 2010, Critical care medicine.

[5]  Richard Beale,et al.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.

[6]  B. Woodward,et al.  Safety of drotrecogin alfa (activated) in severe sepsis: data from adult clinical trials and observational studies. , 2009, Journal of critical care.

[7]  Ricard Ferrer,et al.  Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. , 2009, American journal of respiratory and critical care medicine.

[8]  C. Sprung,et al.  Steroids in patients with septic shock. , 2009, Chest.

[9]  D. Annane,et al.  Adrenal insufficiency in septic shock. , 2009, Clinics in chest medicine.

[10]  M. Levy,et al.  Reducing mortality in severe sepsis: the Surviving Sepsis Campaign. , 2008, Clinics in chest medicine.

[11]  A. Groeneveld,et al.  Should we abandon corticosteroids during septic shock? No , 2008, Current opinion in critical care.

[12]  A. Kalil,et al.  Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis , 2008, PloS one.

[13]  M. Levy,et al.  Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. , 2008, JAMA.

[14]  J. Vincent.  Steroids in sepsis: another swing of the pendulum in our clinical trials , 2008, Critical care.

[15]  Sangeeta Mehta,et al.  Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.

[16]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[17]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[18]  C. Sprung,et al.  Adrenal function in sepsis: The retrospective Corticus cohort study , 2007, Critical care medicine.

[19]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[20]  S. LaRosa.  Use of corticosteroids in the sepsis syndrome: what do we know now? , 2005, Cleveland Clinic journal of medicine.

[21]  F. Blasi,et al.  Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. , 2005, American journal of respiratory and critical care medicine.

[22]  P. Pronovost,et al.  Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. , 2004, Critical care medicine.

[23]  Margaret M Parker,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[24]  N. H. Steigbigel.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[25]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[26]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[27]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[28]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials. , 2000, The New England journal of medicine.

[29]  Bellissant,et al.  Prognostic value of cortisol response in septic shock , 2000, JAMA.

[30]  P. Fontanarosa,et al.  Prognostic value of cortisol response in septic shock. , 2000, JAMA.

[31]  D. Annane,et al.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.

[32]  R. Wunderink,et al.  Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. , 1991, Chest.